FDX-6058

Fulcrum's sickle cell disease program is back in business after FDA lifts 6-month hold
Fierce Biotech
Tue, 08/22/23 - 10:01 am
Fulcrum Therapeutics
sickle cell disease
clinical trials
FDX-6058
FDA placed hold on Fulcrum's sickle cell therapy over hematological malignancy concerns
Fierce Biotech
Thu, 03/9/23 - 11:43 am
FDA
Fulcrum Therapeutics
sickle cell therapy
FDX-6058
clinical hold
Fulcrum's clinical hold caps off tough week for sickle cell drug development
Fierce Biotech
Sun, 02/26/23 - 10:20 pm
Fulcrum Therapeuticsl
FDA
sickle cell disease
clinical trials
FDX-6058
Novartis
Sangamo
Graphite Bio